BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2428598)

  • 1. Pepsin treatment of mammalian plasma generates immunoreactive and biologically active neurotensin-related peptides in micromolar concentrations.
    Carraway RE; Mitra SP; Ferris CF
    Endocrinology; 1986 Oct; 119(4):1519-26. PubMed ID: 2428598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of immunoreactive neurotensin(s) and enkephalin(s) by pepsin-treatment of plasma.
    Carraway RE; Singer EA; Ferris CF; Mitra SP
    Adv Exp Med Biol; 1986; 198 Pt B():169-79. PubMed ID: 3101414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of a biologically active neurotensin-related peptide obtained from pepsin-treated albumin(s).
    Carraway RE; Mitra SP; Cochrane DE
    J Biol Chem; 1987 May; 262(13):5968-73. PubMed ID: 2437111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma protein(s) yields met-enkephalin-related peptides in near-micromolar concentrations when treated with pepsin.
    Singer EA; Mitra SP; Carraway RE
    Endocrinology; 1986 Oct; 119(4):1527-33. PubMed ID: 3093194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precursor forms of neurotensin (NT) in cat: processing with pepsin yields NT-(3-13) and NT-(4-13).
    Carraway RE; Mitra SP
    Regul Pept; 1987 Aug; 18(3-4):139-54. PubMed ID: 3118422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphibian neurotensin (NT) is not xenopsin (XP): dual presence of NT-like and XP-like peptides in various amphibia.
    Carraway R; Ruane SE; Feurle GE; Taylor S
    Endocrinology; 1982 Apr; 110(4):1094-101. PubMed ID: 6977439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid proteolytic generation of neurotensin-related peptide(s) and biologic activity during extraction of rat and chicken gastric tissues.
    Carraway RE
    J Biol Chem; 1984 Aug; 259(16):10328-34. PubMed ID: 6469966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid degradation of neurotensin by stimulated rat mast cells.
    Cochrane DE; Carraway RE; Boucher W; Feldberg RS
    Peptides; 1991; 12(6):1187-94. PubMed ID: 1726119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of xenopsin-related peptides during acid extraction of gastric tissues.
    Carraway RE; Feurle GE
    J Biol Chem; 1985 Sep; 260(20):10921-5. PubMed ID: 3897226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of neurotensin and neuromedin-N within a common precursor from a human pancreatic neuroendocrine tumor.
    Carraway RE; Mitra SP; Feurle GE; Hacki WH
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1323-8. PubMed ID: 3131383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a pancreatic tumor containing vasoactive intestinal peptide, neurotensin, and pancreatic polypeptide.
    Shulkes A; Boden R; Cook I; Gallagher N; Furness JB
    J Clin Endocrinol Metab; 1984 Jan; 58(1):41-8. PubMed ID: 6315763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and immunochemical character of neurotensin-like material in representative vertebrates and invertebrates: apparent conservation of the COOH-terminal region during evolution.
    Carraway R; Ruane SE; Kim HR
    Peptides; 1982; 3(2):115-23. PubMed ID: 7099978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of histamine release by the peptide kinetensin.
    Sydbom A; Ware J; Mogard MH
    Agents Actions; 1989 Apr; 27(1-2):68-71. PubMed ID: 2473637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotensin in plasma: immunochemical and chromatographic character of acid/acetone-soluble material.
    Carraway R; Hammer RA; Leeman SE
    Endocrinology; 1980 Aug; 107(2):400-6. PubMed ID: 7389661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structures of histamine-releasing peptides formed by the action of acid proteases on mammalian albumin(s).
    Carraway RE; Cochrane DE; Boucher W; Mitra SP
    J Immunol; 1989 Sep; 143(5):1680-4. PubMed ID: 2474609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The stability and metabolism of intravenously administered neurotensin in the rat.
    Aronin N; Carraway RE; Ferris CF; Hammer RA; Leeman SE
    Peptides; 1982; 3(4):637-42. PubMed ID: 7134032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma neurotensin in the conscious pig: release by individual food components and effects on exocrine pancreas secretion.
    Cuber JC; Philippe C; Abello J; Corring T; Levenez F; Chayvialle JA
    Pancreas; 1990 May; 5(3):306-13. PubMed ID: 2343043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolism of intravenously infused neurotensin in man and its chromatographic characterization in human plasma.
    Lee YC; Allen JM; Uttenthal LO; Walker MC; Shemilt J; Gill SS; Bloom SR
    J Clin Endocrinol Metab; 1984 Jul; 59(1):45-50. PubMed ID: 6725524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotensin metabolism in the rat: contribution of the kidney.
    Shulkes A; Englin I; Read D; Hardy KJ
    Peptides; 1987; 8(6):961-5. PubMed ID: 3126491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation, structures, and biologic activity of neurotensin-related peptides generated in extracts of avian tissue.
    Carraway RE; Cochrane DE; Ruane SE
    J Biol Chem; 1987 Nov; 262(33):15886-9. PubMed ID: 2445741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.